Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06885918 · ClinicalTrials.gov registry record

ALS Research Collaborative

A clinical trial of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, sponsored by ALS Therapy Development Institute.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT06885918 is a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease that is actively recruiting participants, run by ALS Therapy Development Institute. The registered enrollment target is 2,000 participants, above the 878-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (128% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06885918, a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, is actively recruiting participants, sponsored by ALS Therapy Development Institute.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.

Conditions Studied

Amyotrophic Lateral Sclerosis Motor Neuron Disease ALS (Amyotrophic Lateral Sclerosis) Motor Neuron Disease, Amyotrophic Lateral Sclerosis ALS With Frontotemporal Dementia (ALS/FTD)

Study Locations (1)

Massachusetts

  • ALS Therapy Development Institute - Watertown

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2014-09-12
Est. Completion 2035-01-31

Sponsor

ALS Therapy Development Institute

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06885918

The ClinicalTrials.gov registry entry for NCT06885918 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 878-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (128% higher). The listed sponsor is ALS Therapy Development Institute, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT06885918 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06885918 about?

NCT06885918 is a clinical study titled "ALS Research Collaborative". The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND...

What is the current status of trial NCT06885918?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2014-09-12. Estimated completion is 2035-01-31.

What conditions does trial NCT06885918 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease, ALS (Amyotrophic Lateral Sclerosis), Motor Neuron Disease, Amyotrophic Lateral Sclerosis, ALS With Frontotemporal Dementia (ALS/FTD).

Who is sponsoring clinical trial NCT06885918?

This trial is sponsored by ALS Therapy Development Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06885918 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Amyotrophic Lateral Sclerosis

All registered trials for this condition

Motor Neuron Disease

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.